Julian Baines Buys 85,000 Shares of EKF Diagnostics (LON:EKF) Stock

EKF Diagnostics Holdings plc (LON:EKF) insider Julian Baines bought 85,000 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The stock was bought at an average price of GBX 23 per share, with a total value of £19,550.

EKF Diagnostics Price Performance

Shares of LON EKF opened at GBX 25 on Tuesday. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The company has a market cap of £108.85 million, a price-to-earnings ratio of 18.52 and a beta of 0.57. The stock’s 50-day moving average is GBX 25.89 and its two-hundred day moving average is GBX 27.29. EKF Diagnostics Holdings plc has a 1-year low of GBX 18.40 and a 1-year high of GBX 32.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings data on Tuesday, September 16th. The company reported GBX 0.43 earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. Analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.